Please find all related articles below.
Brussels, 3 April 2014 – EPHA welcomes the majority of the measures adopted yesterday by the European Parliament as part of the revision of the EU Medical Devices Directive (MDD) and the In Vitro Diagnostic Medical Devices (IVD) Directive. After a year and a half of proposals (1) and in-depth discussions, it is time to rebuild the trust of patients around Europe.
“As the protection of patient safety is a paramount objective, the European Parliament has today taken a (...)
With the EU Institutions producing a tremendous amount of reading material every week, it is sometimes hard to discern which direction we should be pointing our limited resources and time. This is even more the case for many of us who are not based in Brussels and might not be familiar with the rather technical and suspiciously similar-sounding jargon emanating from the heart of Europe. This is why we have considered writing this article on the Europe 2020 Strategy Review that came out at (...)
The European Commission is expected to launch its initial mid-term review of the Europe 2020 strategy in early March. This review will need to take stock of both the attention paid to the inclusive growth pillar of Europe 2020 and the progress towards the target. EPHA and EPF propose changes to strengthen the health dimension of the strategy and ways to engage more with civil society.
2014 will be a year of change for the EU, with upcoming European parliamentary elections, to be held in (...)
EPHA is organising a joint debate about the pivotal role that patients should play in creating innovative, affordable and quality technologies and products for poverty-related and neglected diseases.
To register, please RSVP with your full name and contact details at email@example.com by March 6th.
On 4 February 2014, Constantijn van Oranje-Nassau, Head of Cabinet of European Commission Vice-President Neelie Kroes, was invited at the European Policy Centre (EPC) to speak at a conference entitled “The Digital Agenda in Europe - How far from the finishing line?”. According to Oranje-Nassau, it is currently incorrect to talk about a “finishing line” since the information and communication technologies (ICTs), on which the Digital Agenda relies on, are still at (...)
The European Commission introduced its proposal for a revision of the data protection regulations of the EU two years ago, yet despite agreement on a compromise text by the European Parliament in October 2013, completion of a finalised General Data Protection Regulation (GDPR) has now been delayed until after the May elections.
An agreement reached on 22 January between EU Justice Commissioner, Vivian Reding, and representatives of the Greek and incoming Italian Presidency, has set the new (...)
On 3rd December 2013, different stakeholders of the healthcare system including nurses, social care workers, doctors, patients, citizens, researchers and industry met in Warsaw for the kick-off meeting of the ENS4Care project, with the ambition of developing together evidence based guidelines on eHealth services for nursing and social care.
Although most of the stakeholders met yesterday for the first time, the dynamism, creativity and commitment to work together in designing guidelines (...)
The second Conference of Partners entitled ’Scaling up for healthy growth’ presented the progress that the European Innovation Partnership on Healthy and Active Ageing (EIP on AHA) has made over the last year in the EIP’s six action areas. It highlighted ageing-related innovation, both social and technological, as a crucial area for health investment.
The conference was opened by European Commissioner for Health Policy, Tonio Borg who stressed the need for health system (...)
The European Commission has recently published a Staff Working Document (SWD) exploring the potential of Personalised Medicine, reporting on recent developments in the EU legislation, as well as looking at the factors affecting the uptake of personalised medicine in healthcare systems.
Personalised Medicine is now more close to be effective to patients, which means that treatments can be designed taking into account a specific patient group and hence able to tackle the problem with the (...)
Access to Medicines
Pharmaceuticals and Medicines
Health Rights and Patients
On 22 October, the European Parliament (EP) voted in plenary on one of the most discussed pieces of legislation in recent months, the proposals for Regulations on Medical Devices and In Vitro Diagnostic (IVD) Medical Devices. The newly-approved rules will bring more transparency during the entire process. Some provisions were rejected, such as the centralised pre-market authorisation system (PMA) and the provision stating that certain devices may only be supplied upon medical prescription. (...)